Leveraging Physics and Quantum Computing to Accelerate Drug Discovery
Novel computational techniques are revolutionizing the way we discover new drugs. Robert Marino, CEO and…
Novel computational techniques are revolutionizing the way we discover new drugs. Robert Marino, CEO and…
For cell therapy to become mainstream, important issues such as management of risk and quality…
Søren Møller, Managing Investment Director at Novo Seeds, discusses how the firm’s investment strategy has…
With a tumultuous year behind us, 2021 is set out to spell change for many…
In just a couple of decades, immuno-oncology has taken center stage in the biotechnology industry.…
Augmented reality is starting to become a part of the manufacturing process of pharma and…
The Covid-19 pandemic created an opportunity for many biotech companies to repurpose their existing programs…
The Covid-19 pandemic has pushed investment and research into vaccines and public health, but will…
Jonathan Frampton, Corporate Development Partner at Horizon Discovery, a Perkin Elmer company, shares his insights…
Despite the promise of several approved Covid-19 vaccines and the widespread rollout of vaccination programs…
Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the…
Robotics and artificial intelligence are rapidly changing the way we discover drugs. Martin-Immanuel Bittner, CEO…